Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesAmortization of GoodwillAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Maravai Lifesciences Holdings (MRVI) Amortizatization of Intangibles (2020 - 2025)

Historic Amortizatization of Intangibles for Maravai Lifesciences Holdings (MRVI) over the last 6 years, with Q3 2025 value amounting to $7.2 million.

  • Maravai Lifesciences Holdings' Amortizatization of Intangibles rose 461.47% to $7.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $28.3 million, marking a year-over-year increase of 306.57%. This contributed to the annual value of $27.5 million for FY2024, which is 63.97% up from last year.
  • As of Q3 2025, Maravai Lifesciences Holdings' Amortizatization of Intangibles stood at $7.2 million, which was up 461.47% from $7.2 million recorded in Q2 2025.
  • Over the past 5 years, Maravai Lifesciences Holdings' Amortizatization of Intangibles peaked at $7.2 million during Q3 2025, and registered a low of $3.7 million during Q4 2021.
  • Moreover, its 5-year median value for Amortizatization of Intangibles was $6.9 million (2023), whereas its average is $6.3 million.
  • In the last 5 years, Maravai Lifesciences Holdings' Amortizatization of Intangibles plummeted by 2924.09% in 2021 and then skyrocketed by 7066.23% in 2022.
  • Over the past 5 years, Maravai Lifesciences Holdings' Amortizatization of Intangibles (Quarter) stood at $3.7 million in 2021, then soared by 70.66% to $6.2 million in 2022, then rose by 10.15% to $6.9 million in 2023, then grew by 0.48% to $6.9 million in 2024, then grew by 4.45% to $7.2 million in 2025.
  • Its last three reported values are $7.2 million in Q3 2025, $7.2 million for Q2 2025, and $7.0 million during Q1 2025.